Genzyme Announces EMA Accepts Oral Teriflunomide Marketing Application for Treatment of Multiple Sclerosis Genzyme, 23 Feb 2012 Accessed on 13 Jun 2012 from http://www.businesswire.com/news/genzyme/20120223005819/en. CommentRecommendBookmarkWatch